Before BC Cancer can offer a clinical trial to patients, the trial must undergo scientific and ethical review by a Research Ethics Board (REB).
Government agencies in countries that oversee clinical trials also regulate how researchers conduct these studies. These agencies set the rules for clinical trials and help ensure that REBs include the approrpiate mix of experts to review research.
In Canada, Health Canada reviews and approves clinical trials involving new drugs.
At BC Cancer, specialists work together in tumour-specific teams called tumour groups. Examples include:
- Breast Tumour Group
- Genitourinary Tumour Group
- Gastrointestinal Tumour Group
These groups include physicians and other health professionals, such as nurses, pharmacists, counsellors and researchers.
Depending on the type of cancer, physician members may include surgeons, medical oncologists, radiation oncologists and other specialists.
Tumour Group members work together to identify important questions in cancer care and treatment. They also consult with scientists to determine where more research is needed. Based on these priorities, they develop or support clinical trials designed to improve cancer treatment and patient ourcomes.
Once a tumour group approves a clinical trial protocol and the trial receives all required regulatory approvals, BC Cancer may offer the trial at one or more cancer centres across the province.
Most Phase I clinical trials at BC Cancer are currently offered in Vancouver. Phase II and Phase III clinical trials may be available at any BC Cancer centre.
If a trial is not available at your local centre, you may want to consider travelling to another BC Cancer location to participate. Your doctor can help you decide whether this is a suitable option.
Individual tumour group members sometimes develop clinical trial. More often, larger groups of physicians and researchers work together to design studies.
BC Cancer physicians frequently participate in cooperative group trials, where multiple cancer treatment centres collaborate on the same research study.
In Canada, the National Cancer Institute of Canada (NCIC) has played a major role in developing and coordinating cancer clinical trials. Other cooperative groups across North America also develop clinical trials that may be available through BC Cancer.
In some cases, pharmaceutical companies develop clinical trials in collaboration with cancer specialists.
Clinical trials may be sponsored by:
- BC Cancer
- Cooperative research groups, such as the NCIC
- Pharmaceutical companies
- A combination of these organizations
Pharmaceutical companies often provide funding, study drugs and other resources needed for the research. They may also help collect and analyze study data.
Your oncologist can tell you whether any clinical trials at your treatment centre may be suitable for you. If a clinical trial is an option, your oncologist will discuss it alongside standard treatment options.
If you decide to participate, you will usually need additional tests to confirm that you meet the study's eligibility requirements.
You can search for clinical trials at each of the BC Cancer centres using the clinical trials search page.
You can also look for clinical trials outside your local area if you are willing to travel. Your oncologist can help you understand available trial information and may be able to help determine whether you meet the eligibility requirements for a trial at another centre.
Please note that oncologists cannot continually track all clinical trials taking place in every province, state or country. As a result, they may not be able to provide detailed advice about every research study available outside BC Cancer.